These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 17659340)
1. Expression of TCL-1 as a potential prognostic factor for treatment outcome in B-cell chronic lymphocytic leukemia. Browning RL; Geyer SM; Johnson AJ; Jelinek DF; Tschumper RC; Call TG; Shanafelt TD; Zent CS; Bone ND; Dewald GW; Lin TS; Heerema NA; Grever MR; Kay NE; Byrd JC; Lucas DM Leuk Res; 2007 Dec; 31(12):1737-40. PubMed ID: 17659340 [TBL] [Abstract][Full Text] [Related]
2. Combination chemoimmunotherapy with pentostatin, cyclophosphamide, and rituximab shows significant clinical activity with low accompanying toxicity in previously untreated B chronic lymphocytic leukemia. Kay NE; Geyer SM; Call TG; Shanafelt TD; Zent CS; Jelinek DF; Tschumper R; Bone ND; Dewald GW; Lin TS; Heerema NA; Smith L; Grever MR; Byrd JC Blood; 2007 Jan; 109(2):405-11. PubMed ID: 17008537 [TBL] [Abstract][Full Text] [Related]
3. Rituximab plus fludarabine and cyclophosphamide or other agents in chronic lymphocytic leukemia. Robak T; Lech-Maranda E; Robak P Expert Rev Anticancer Ther; 2010 Oct; 10(10):1529-43. PubMed ID: 20942624 [TBL] [Abstract][Full Text] [Related]
4. Chronic lymphocytic leukemia: current and emerging treatment approaches. Kay NE; Rai KR; O'Brien S Clin Adv Hematol Oncol; 2006 Nov; 4(11 Suppl 22):1-10; quiz 11-2. PubMed ID: 17143256 [TBL] [Abstract][Full Text] [Related]
5. Mcl-1 expression predicts progression-free survival in chronic lymphocytic leukemia patients treated with pentostatin, cyclophosphamide, and rituximab. Awan FT; Kay NE; Davis ME; Wu W; Geyer SM; Leung N; Jelinek DF; Tschumper RC; Secreto CR; Lin TS; Grever MR; Shanafelt TD; Zent CS; Call TG; Heerema NA; Lozanski G; Byrd JC; Lucas DM Blood; 2009 Jan; 113(3):535-7. PubMed ID: 19008456 [TBL] [Abstract][Full Text] [Related]
6. The addition of rituximab to fludarabine improves clinical outcome in untreated patients with ZAP-70-negative chronic lymphocytic leukemia. Del Poeta G; Del Principe MI; Consalvo MA; Maurillo L; Buccisano F; Venditti A; Mazzone C; Bruno A; Gianní L; Capelli G; Lo Coco F; Cantonetti M; Gattei V; Amadori S Cancer; 2005 Dec; 104(12):2743-52. PubMed ID: 16284990 [TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of front-line therapy with fludarabine-cyclophosphamide-rituximab regimen for chronic lymphocytic leukemia outside clinical trials: the Israeli CLL Study Group experience. Herishanu Y; Goldschmidt N; Bairey O; Ruchlemer R; Fineman R; Rahimi-Levene N; Shvidel L; Tadmor T; Ariel A; Braester A; Shapiro M; Joffe E; Polliack A; Haematologica; 2015 May; 100(5):662-9. PubMed ID: 25661442 [TBL] [Abstract][Full Text] [Related]
8. [Efficacy of chemoimmunotherapy with fludarabine, cyclophosphamide and rituximab for chronic lymphocytic leukemia]. Fang C; Xu W; Xu M; Hong M; Zhu DX; Zhu HY; Wu YJ; Fan L; Qiao C; Zhuang Y; Miao KR; Liu P; Li JY Zhonghua Xue Ye Xue Za Zhi; 2011 Jan; 32(1):3-7. PubMed ID: 21429392 [TBL] [Abstract][Full Text] [Related]
9. [Treatment of chronic lymphocytic leukemia with regimen of fludarabine, cyclophosphamide and rituximab]. Gu WJ; Xu W; Qian SX; Wu YJ; Hong M; Chen LJ; Wu HX; Lu H; Qiu HX; Li JY Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Aug; 16(4):938-42. PubMed ID: 18718095 [TBL] [Abstract][Full Text] [Related]
10. Community-based phase II trial of pentostatin, cyclophosphamide, and rituximab (PCR) biochemotherapy in chronic lymphocytic leukemia and small lymphocytic lymphoma. Dillman RO; Schreeder MT; Hon JK; Connelly EF; DePriest C; Cutter K Cancer Biother Radiopharm; 2007 Apr; 22(2):185-93. PubMed ID: 17600465 [TBL] [Abstract][Full Text] [Related]
11. Pentostatin and rituximab in the treatment of patients with B-cell malignancies. Drapkin R Oncology (Williston Park); 2000 Jun; 14(6 Suppl 2):25-9. PubMed ID: 10887641 [TBL] [Abstract][Full Text] [Related]
12. Early results of a chemoimmunotherapy regimen of fludarabine, cyclophosphamide, and rituximab as initial therapy for chronic lymphocytic leukemia. Keating MJ; O'Brien S; Albitar M; Lerner S; Plunkett W; Giles F; Andreeff M; Cortes J; Faderl S; Thomas D; Koller C; Wierda W; Detry MA; Lynn A; Kantarjian H J Clin Oncol; 2005 Jun; 23(18):4079-88. PubMed ID: 15767648 [TBL] [Abstract][Full Text] [Related]
13. Community-based phase II trial of PCR for CLL/SLL patients. Kay NE; Shanafelt TD; Byrd JC; Grever MR Cancer Biother Radiopharm; 2007 Oct; 22(5):713-4; author reply 715-7. PubMed ID: 17979574 [No Abstract] [Full Text] [Related]
14. Pentostatin/cyclophosphamide with or without rituximab: an effective regimen for patients with Waldenstrom's macroglobulinemia/lymphoplasmacytic lymphoma. Hensel M; Villalobos M; Kornacker M; Krasniqi F; Ho AD Clin Lymphoma Myeloma; 2005 Sep; 6(2):131-5. PubMed ID: 16231851 [TBL] [Abstract][Full Text] [Related]